This research study is for patients that have been diagnosed with chronic uveitis, a disease
that causes inflammation in the eye. Patients are currently being treated with Remicade,
Humira, Methotrexate and or similar chemotherapy type drugs to control this inflammation.
Despite these medications, patients still have inflammation in their eyes. Patients are being
asked to add an additional drug, thalidomide.